Analyst Ratings for Carisma Therapeutics Inc (CARM)

CARM Rating Summary

  |   Expand Research on CARM
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 3.3 / 10   Percentile Rank: 30%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
12/16/2024 H.C. Wainwright Mitchell Kapoor Downgrade Neutral
(Buy)		 N/A
(N/A)		 0.40
(0.15)		 -62.5% Details
12/12/2024 Baird Jack Allen Downgrade Neutral
(Outperform)		 1.00
(10.00)		 0.69
(0.15)		 -78.26% Details